[225Ac]Pep-1L

N/A

Report date: 2025/11/20 16:03:51

NME

Base Information

Drug Name[225Ac]Pep-1L

Drug Alias Name225Ac-Pep-1L

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionInterleukin-13 receptor subunit alpha-2 binders

TargetsInterleukin-13 receptor subunit alpha-2

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesWake Forest University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesWake Forest University School Of Medicine

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A